Literature DB >> 28260005

Clinical significance of the phosphorylation of MAPK and protein expression of cyclin D1 in human osteosarcoma tissues.

Jian Wu1, Lei-Lei Cui1, Jun Yuan1, Yuan Wang2, Shu Song3.   

Abstract

The aim of the present study was to investigate the significance of the phosphorylation of mitogen-activated protein kinase (MAPK) and the protein expression of cyclin D1 in human osteosarcoma tissues. Human osteosarcoma tissue samples were collected from 30 patients, benign bone tumor samples were collected from 30 patients, and normal bone tissues were collected from 10 individuals as controls. Immunohistochemistry was performed to measure the levels of phosphorylated (p)-MAPK and cyclin D1 protein in cases of human osteosarcoma. The results showed that the positive rates of MAPK and cyclin D1 in osteosarcoma were 86.67% (26/30) and 73.00% (22/30), respectively. The positive staining rates of MAPK and cyclin D1 in benign bone tumor tissues were 10.00% (3/30) and 3.30% (1/30), respectively. The positive rate in the normal bone tissues was 0% (0/30), which was significantly lower, compared with that of the cancerous bone tissue. The positive rates of MAPK and cyclin D1 in osteosarcoma were increased (P<0.05), and the expression of cyclin D1 and p‑MAPK were positively correlated. The phosphorylation of MAPK may be important in the development of osteosarcoma, and the overactivation of MAPK may induce high expression of cyclin D1 and induce tumor cells to proliferate continuously.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28260005     DOI: 10.3892/mmr.2017.6224

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  10 in total

1.  Novel application of single-cell next-generation sequencing for determination of intratumoral heterogeneity of canine osteosarcoma cell lines.

Authors:  Jordan Ayers; Rowan J Milner; Galaxia Cortés-Hinojosa; Alberto Riva; Sandra Bechtel; Bikash Sahay; Matthew Cascio; Amandine Lejeune; Keijiro Shiomitsu; Carlos Souza; Oscar Hernandez; Marc Salute
Journal:  J Vet Diagn Invest       Date:  2021-01-15       Impact factor: 1.279

2.  MicroRNA-466 inhibits osteosarcoma cell proliferation and induces apoptosis by targeting CCND1.

Authors:  Wei Cao; Le Fang; Siyong Teng; Hongwei Chen; Tiejun Liu
Journal:  Exp Ther Med       Date:  2018-10-22       Impact factor: 2.447

3.  Canine osteosarcoma genome sequencing identifies recurrent mutations in DMD and the histone methyltransferase gene SETD2.

Authors:  Cheryl A London; William P D Hendricks; Heather L Gardner; Karthigayini Sivaprakasam; Natalia Briones; Victoria Zismann; Nieves Perdigones; Kevin Drenner; Salvatore Facista; Ryan Richholt; Winnie Liang; Jessica Aldrich; Jeffrey M Trent; Peter G Shields; Nicholas Robinson; Jeremy Johnson; Susan Lana; Peter Houghton; Joelle Fenger; Gwendolen Lorch; Katherine A Janeway
Journal:  Commun Biol       Date:  2019-07-19

4.  lncRNA FLVCR-AS1 promotes osteosarcoma growth by targeting miR381-3p/CCND1.

Authors:  Guang Yang; Fei He; Hao Duan; Jianlin Shen; Qirong Dong
Journal:  Onco Targets Ther       Date:  2020-01-09       Impact factor: 4.147

5.  Immunoexpression of Ki67, p53 and cyclin D1 in osteosarcomas.

Authors:  Ştefan Adrian Niculescu; Dan Cristian Grecu; Cristiana Eugenia Simionescu; Elena Carmen Niculescu; Mioara Desdemona Stepan; Alex Emilian Stepan
Journal:  Rom J Morphol Embryol       Date:  2021 Jul-Sep       Impact factor: 0.833

Review 6.  The Interaction Between Autophagy and JAK/STAT3 Signaling Pathway in Tumors.

Authors:  Jiangyan Xu; Jinrong Zhang; Qi-Fen Mao; Jian Wu; Yuan Wang
Journal:  Front Genet       Date:  2022-04-26       Impact factor: 4.772

Review 7.  Advances in multi-omics research on viral hepatitis.

Authors:  Ze Xiang; Jiayuan Li; Di Lu; Xuyong Wei; Xiao Xu
Journal:  Front Microbiol       Date:  2022-09-02       Impact factor: 6.064

8.  Fc receptor-like 5 gene polymorphisms and mRNA expression are associated with liver fibrosis in chronic hepatitis B.

Authors:  Jiajia Yang; Juan Gu; Hongmei Wang; Jiayin Shi; Lingyun Lu; Wanxian She; Ying Wang
Journal:  Front Microbiol       Date:  2022-09-09       Impact factor: 6.064

Review 9.  Advances in the application of proteomics in lung cancer.

Authors:  Bai Ling; Zhengyu Zhang; Ze Xiang; Yiqi Cai; Xinyue Zhang; Jian Wu
Journal:  Front Oncol       Date:  2022-09-27       Impact factor: 5.738

10.  Correlation between LncRNA-LINC00659 and clinical prognosis in gastric cancer and study on its biological mechanism.

Authors:  Yongjia Sheng; Chenyang Han; Yi Yang; Jin Wang; Yanling Gu; Wenyan Li; Li Guo
Journal:  J Cell Mol Med       Date:  2020-11-03       Impact factor: 5.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.